Predictors of response to immune checkpoint inhibition in a real world gynecologic cancer population

Predictors of response to immune checkpoint inhibition in a real world gynecologic cancer population

Prognostic factors for immune checkpoint inhibitor (CPI) response in gynecologic cancer are limited. This retrospective study aimed to identify prognostic factors associated with improved overall response rate (ORR) and progression free survival (PFS) in gynecologic cancer patients receiving at leas...

Full description

Bibliographic Details
Main Authors: Michelle L. Kuznicki, Carrie Bennett, Meng Yao, Amy Joehlin-Price, Peter G. Rose, Haider Mahdi
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Gynecologic Oncology Reports
Subjects:
Checkpoint inhibition
Gynecologic cancer
Immune toxicity
Clear cell histology
Recurrent endometrial cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578920301375

Internet

http://www.sciencedirect.com/science/article/pii/S2352578920301375

Similar Items